News for 'US Generics'

Ranbaxy, Reddy's vie for US cholesterol drug mart

Ranbaxy, Reddy's vie for US cholesterol drug mart

Rediff.com3 May 2006

Simvastatin goes off patent in late June; Ranbaxy gets 180-day exclusivity period; Dr Reddy's-Merck will be third player.

Aurobindo Pharma embroiled in patent cases in the US

Aurobindo Pharma embroiled in patent cases in the US

Rediff.com28 Apr 2014

According to the petition copies, Hospira has alleged that Aurobindo's Abbreviated New Drug Application (ANDA) to make generic version of dexmedetomidine hydrochloride injection would infringe its patented drug Precedex.

Bigger role seen for biopharma

Bigger role seen for biopharma

Rediff.com18 Apr 2006

Pfizer set to buy Allergan for more than $150 bn

Pfizer set to buy Allergan for more than $150 bn

Rediff.com23 Nov 2015

The deal would involve Pfizer paying with 11.3 of its shares for each Allergan share.

'Our risk is now being managed'

'Our risk is now being managed'

Rediff.com10 Mar 2006

The US continues to be the most important part of our overseas portfolio

Wockhardt gets US nod for Zonisamide

Wockhardt gets US nod for Zonisamide

Rediff.com26 Dec 2005

Wockhardt has received United States Food & Drug Administration approval to market Zonisamide capsules.

What we MISS when we don't watch films in a theatre

What we MISS when we don't watch films in a theatre

Rediff.com27 Jan 2021

The difference between watching a movie on a laptop in your apartment and watching it on a big white screen is almost spiritual, notes Sreehari Nair.

US groups criticise India's drug, tech, farm policies

US groups criticise India's drug, tech, farm policies

Rediff.com14 Mar 2013

Last year, India's agricultural exports to the United States topped $5 billion.

Rise and fall in Indo-US trade over the years

Rise and fall in Indo-US trade over the years

Rediff.com29 Sep 2014

Trade has grown steadily since 2004, before flattening out in the past couple of years.

Ranbaxy 'systematically violated' norms: Whistleblower

Ranbaxy 'systematically violated' norms: Whistleblower

Rediff.com14 May 2013

The generic drugs at issue were manufactured at Ranbaxy's facilities in Paonta Sahib and Dewas in India and included acne drug Sotret, epilepsy and nerve pain drug gabapentin and antibiotic ciprofloxacin.

How the jewellers plan to achieve $60-billion export target

How the jewellers plan to achieve $60-billion export target

Rediff.com7 Apr 2017

Prime Minister Narendra Modi had asked exporters to prepare a strategy for the next five years and start working in that direction.

Ranbaxy launches Clarithromycin in US

Ranbaxy launches Clarithromycin in US

Rediff.com24 May 2005

Ranbaxy Laboratories Ltd on Tuesday launched its approved generic formulation of Clarithromycin immediate release tablets in the US market.

'Cipla has emerged as a great catchment area for talent'

'Cipla has emerged as a great "catchment area" for talent'

Rediff.com20 Aug 2020

An insider said that over the past decade or so Cipla has become immune to the exits of leaders. There have been no directional change in the long-term strategies.

How Gujarat plans to help its pharma companies

How Gujarat plans to help its pharma companies

Rediff.com25 Apr 2013

The state govt has raised drug procurement budget.

Economic recovery still not well entrenched: RBI Guv

Economic recovery still not well entrenched: RBI Guv

Rediff.com16 Sep 2020

Observing that the economic recovery was not yet fully entrenched, the RBI Governor said recovery is likely to be gradual.

Pharma R&D: Basic drug research only a part

Pharma R&D: Basic drug research only a part

Rediff.com22 Apr 2013

Spending allocation covers salaries, consultancy, litigation, material expense and regulatory costs.

Why GSK is changing its strategy after 93 years

Why GSK is changing its strategy after 93 years

Rediff.com4 Sep 2017

Increased price control over branded generic medicines has affected its profitability

7 habits of highly successful people

7 habits of highly successful people

Rediff.com4 Sep 2013

Practice these seven easy habits and you'll be amazed at the results, says Aditya Prasad, chief evangelist at Perfios.com.

India should take US pharma complaints seriously

India should take US pharma complaints seriously

Rediff.com25 Jun 2013

The worry is that India's cavalier approach to intellectual property may catch on in other parts of the developing world

Ranbaxy recalls AIDS drugs

Ranbaxy recalls AIDS drugs

Rediff.com10 Nov 2004

Ranbaxy Laboratories has withdrawn all of its generic versions of antiretroviral drugs from World Health Organization's list of approved HIV medicines, saying it's uncertain they are biologically the same as the patented drugs.

Ranbaxy whistle-blower to talk on quality of Made-in-India drugs

Ranbaxy whistle-blower to talk on quality of Made-in-India drugs

Rediff.com27 Feb 2014

Whistle-blower Dinesh Thakur will speak on Made-in-India drugs at an event in Washington.

Column: What was the Novartis case really about?

Column: What was the Novartis case really about?

Rediff.com8 Apr 2013

The drug Glivec was a genuinely new and important discovery deserving of patent protection.

USFDA raises concerns about Ranbaxy's Toansa plant

USFDA raises concerns about Ranbaxy's Toansa plant

Rediff.com13 Jan 2014

All of Ranbaxy's India-based factories are currently banned by the FDA from exporting medicines to the United States, the company's largest market, after the regulator's inspection found violation of its so-called good manufacturing practices.

GlaxoSmithKline sues Dr Reddy's

GlaxoSmithKline sues Dr Reddy's

Rediff.com31 Dec 2003

GlaxoSmithKline has filed a lawsuit in a United States court against Dr Reddy's Laboratories alleging infringement of patent rights of a generic version of 'Imitrex' drug, used for the treatment of migraine.

Drug makers pay lip service to R&D in India

Drug makers pay lip service to R&D in India

Rediff.com13 Jun 2013

Companies known for spending huge amounts on innovation globally have minuscule budgets for India. What's holding them back?

Patent row: Pfizer sues Ranbaxy

Patent row: Pfizer sues Ranbaxy

Rediff.com22 Feb 2005

Ranbaxy a wake-up call for Indian pharma

Ranbaxy a wake-up call for Indian pharma

Rediff.com25 May 2013

Industry must take strong collective action to protect the reputation it enjoys in global markets, says Kiran Mazumdar Shaw.

Street vendors left out of Unlock 1.0's purview

Street vendors left out of Unlock 1.0's purview

Rediff.com7 Jul 2020

'In states where all shops are allowed to function and pedestrians are allowed to move around, there is no reason to presume that vendors are not allowed to operate. But ambiguity surrounding the operation of street vendors de jure has led the police to harass them de facto,' say Bhuvana Anand, Jayana Bedi and Prashant Narang.

Ranbaxy set for a big catch in US

Ranbaxy set for a big catch in US

Rediff.com12 Sep 2005

Ranbaxy to pay $500 mn to settle US fraud charges

Ranbaxy to pay $500 mn to settle US fraud charges

Rediff.com14 May 2013

Firm pleads guilty to lying to US FDA; says it had set aside the money.

Ranbaxy AIDS drugs back in WHO list

Ranbaxy AIDS drugs back in WHO list

Rediff.com19 Aug 2005

A random check had found that tests failed to prove the medicines were same as the patented drugs.\n

US FDA likely to inspect new Visakhapatnam arm of Divi's Labs in Jan

US FDA likely to inspect new Visakhapatnam arm of Divi's Labs in Jan

Rediff.com31 Dec 2013

The move assumes significance because a go-ahead from the US Food and Drug Administration for the new unit in Visakhapatnam is likely to give a huge boost to the company's revenues in upcoming quarters.

Future healthy for drug firms

Future healthy for drug firms

Rediff.com6 Nov 2004

Manoj Sinha's ambitious plans for J&K

Manoj Sinha's ambitious plans for J&K

Rediff.com21 Oct 2020

For far too long, people in J&K have felt the government doesn't exist for them.' 'My first priority is to make them feel that not only does it exist, it is there to work for them.

Like the Dhoom 3 trailer? VOTE!

Like the Dhoom 3 trailer? VOTE!

Rediff.com6 Sep 2013

Dhoom 3 boasts of more noise, more bikes and a whole lot of scowling from Aamir Khan.

Bird flu: Indian firms may make patented drug

Bird flu: Indian firms may make patented drug

Rediff.com20 Oct 2005

Indian companies may be able to make generic copies of Roche's anti-influenza drug Tamiflu with its patent still pending in the country.